Philips Launches Transcend Plus For EPIQ CVx And Affiniti CVx, Delivering Breakthrough Image Quality And FDA

26 FDA-cleared AI applications, now fully integrated Philips now offers 26 FDA-cleared cardiovascular ultrasound AI applications—the most in the industry—fully integrated into Transcend Plus for both EPIQ and Affiniti CVx systems. Among the latest enhancements to receive FDA 510(k) clearance are 2D Auto EF and 2D Auto EF Advanced. These advanced tools are designed to streamline clinical workflows and improve diagnostic accuracy across a range of care settings, from the echo lab through the hospital to outpatient clinics, pre-assessment, and long-term follow-up. With these integrated AI applications, clinicians can assess patients more quickly, consistently, and confidently across the entire care continuum. Why left ventricular function assessment matters Left ventricular (LV) function assessment is one of the most critical applications in cardiac imaging, playing a central role in diagnosing and managing a wide range of cardiac conditions. Transcend Plus directly supports this need by delivering fast, reproducible results that help cardiologists quickly and definitively evaluate LV function consistently across different patients and over time. Automated tools minimize operator variability, ensuring more reliable and standardized measurements, especially vital in high-volume or high-pressure clinical environments. In addition, Transcend Plus offers robust support for both contrast and non-contrast imaging. The 2D Auto EF feature enables accurate assessments even when contrast agents cannot be used, such as in patients with renal impairment. Building on this, 2D Auto EF Advanced adds AI-powered quantification capabilities for both contrast and non-contrast studies, broadening clinical applicability and enhancing measurement reliability in patients with poor image quality or challenging acoustic windows. These capabilities combine to deliver a more confident, efficient approach to cardiac care. Clinical confidence, anywhere, anytime Transcend Plus empowers clinicians to make fast, confident decisions across every cardiac care setting—whether in the echo lab, interventional suite, or during routine outpatient assessments. By delivering sharper imaging and intelligent automation, it enables more informed care, streamlines workflows, and helps providers manage growing patient volumes without compromising diagnostic quality or clinician well-being. Transcend Plus delivers three core benefits: enhanced image quality for clearer visualization of cardiac anatomy and improved diagnostic precision; advanced AI integration, with 26 FDA-cleared applications that automate and accelerate routine tasks; and faster, more actionable insights that reduce delays and support timely, evidence-based clinical decisions throughout the care journey. Philips Ultrasound systems installed around the world perform an estimated 1.33 billion diagnostic and interventional procedures each year, supporting diagnosis and treatment for 654 million unique patients annually. Transcend Plus will be demonstrated live at the European Society of Cardiology 2025 Congress (ESC) in Madrid (Aug. 29 – Sept. 1) and the American Society of Echocardiography annual meeting (ASE) in Nashville (Sept. 5 – Sept. 7), offering hands-on clinical insight into how these innovations are transforming cardiac ultrasound. Visit Philips Cardiovascular Ultrasound for more information.